No need for constant help: human IgG2 antibodies have an autonomous agonistic activity for immunotherapy of cancer.
Cancer Cell
; 27(1): 10-1, 2015 Jan 12.
Article
en En
| MEDLINE
| ID: mdl-25584890
ABSTRACT
Agonistic antibodies specific for members of the tumor necrosis factor receptor protein family hold great promise for immunotherapy of cancer. In this issue of Cancer Cell, White and colleagues provide evidence that the human IgG2 subclass may represent a superior backbone for the use of these antibodies in human therapy.
Texto completo:
1
Colección:
01-internacional
Base de datos:
MEDLINE
Asunto principal:
Timoma
/
Neoplasias del Timo
/
Inmunoglobulina G
/
Receptores de IgG
/
Anticuerpos Monoclonales
Límite:
Animals
/
Humans
Idioma:
En
Revista:
Cancer Cell
Asunto de la revista:
NEOPLASIAS
Año:
2015
Tipo del documento:
Article
País de afiliación:
Alemania